Position in EPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,892,361
+$410,470 QoQ
Shares Held
261,376
+33.2% QoQ
Ownership
0.400%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 54 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ROYAL BANK OF CANADA holds $1,974,352,961 across 412 Biotechnology names. EPRX ranks #41 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,111,871 | $496,494,870 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
3,801,815 | $285,478,282 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
351,171 | $271,328,756 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
791,515 | $261,888,563 | |
| 5 | INCY |
Incyte Corp
|
1,054,123 | $99,214,053 | |
| 6 | INSM |
INSMED Inc
|
523,101 | $85,537,473 | |
| 7 | MRNA |
Moderna, Inc.
|
999,340 | $50,766,470 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
658,290 | $42,545,279 |
All Filings in EPRX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,892,361 | 261,376 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,481,891 | 196,277 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,529,943 | 428,804 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,468,643 | 428,584 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $1,124,475 | 342,828 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $897,569 | 283,145 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $713,484 | 271,287 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $685,619 | 265,744 | Shares | Defined | 2024-11-06 | |
| No filing history on record for this holder in this stock. | ||||||